• Anasayfa
  • Hakkında
  • Politika
  • İletişim
    • English
    • Türkçe
  • Türkçe 
    • English
    • Türkçe
  • Giriş
Gelişmiş Arama
Öğe Göster 
  •   Ana Sayfa
  • Tüm Akademik Yayınlar
  • Yayınlar - Eserler
  • Öğe Göster
  •   Ana Sayfa
  • Tüm Akademik Yayınlar
  • Yayınlar - Eserler
  • Öğe Göster
JavaScript is disabled for your browser. Some features of this site may not work without it.

Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled,open-label study.

Thumbnail
Göster/Aç
33- Low molecular weight heparin treatment of acute moderate and severe pancreatitis A randomized, controlled,open-label study.pdf (147.2Kb)
Tarih
2019-01-01
Yazar
Baysal, Birol
Şentürk, HAKAN
İNCE, ALİ TÜZÜN
Kayar, Yusuf
Tozlu, Mukaddes
Danışman
Türü
Article
Üst veri
Tüm öğe kaydını göster
Özet
Background/Aims: Acute pancreatitis (AP) runs a moderately severe and severe course in 20%-30% of cases. The purpose of the present study was to determine the effect of low molecular weight heparin (LMWH) for the prevention of pancreatic necrosis (PN) in moderately severe and severe AP (MSAP). Materials and Methods: A total of 100 patients with MSAP were randomized to receive either standard care (SC) or SC plus LMWH. LMWH was administered at 1 mg/kg via subcutaneous injection twice a day between days 1 and 7. The revised Atlanta criteria were used in the diagnosis of MSAP. Patients with a Harmless AP Score of ≥1 and a Balthazar computed tomography (CT) score of D and E were included in the study. Results: The mean age±SD of the patients (46 male and 54 female) was 52±19 years (range, 17-100). There were 50 patients in each group. On admission, clinical and laboratory parameters and Balthazar CT scores were similar between the groups. Initially, PN was present in one patient in the LMWH group and two in the SC group. Over the course, PN developed in 3 (6.1%) patients in the LMWH group and 11 (22.9%) in the SC group (p<0.05). Local and systemic complications were significantly lower in the LMWH group (p<0.05). No hemorrhagic complication occurred. Mortality was not significantly different between the groups (p=0.056). Conclusion: Low molecular weight heparin treatment is safe and provides better prognosis in MSAP.
Konu
Tozlu M., Kayar Y., İNCE A. T. , Baysal B., Şentürk H., -Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled,open-label study.-, TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.30, ss.81-87, 2019
Bağlantı
https://hdl.handle.net/20.500.12645/7939
Koleksiyonlar
  • Tıp Fakültesi [2546]
  • Yayınlar - Eserler [9994]

BEZMIALEM VAKIF UNIVERSITY

About us |Policies | Library | Contact us | Send Feedback | Sitemap | Admin

Bezmialem Vakıf Üniversitesi, Adnan Menderes Bulvarı Vatan Caddesi 34093 Fatih, İstanbul / TURKEY
Copyright © Bezmialem Vakıf Üniversitesi

Creative Commons Lisansı
Bezmialem Institutional Repository, Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.

OpenAccess@BVU

Support by  UNIREPOS


Bezmialem Kütüphane


OpenAccess@BVU validated by OpenAIRE

sherpa/romeo

Göz at

Tüm DSpaceBölümler & KoleksiyonlarTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile göreErişim Hakkına GöreDanışmana GöreBu KoleksiyonTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile göreErişim Hakkına GöreDanışmana Göre

Hesabım

GirişKayıt

BEZMIALEM VAKIF UNIVERSITY

About us |Policies | Library | Contact us | Send Feedback | Sitemap | Admin

Bezmialem Vakıf Üniversitesi, Adnan Menderes Bulvarı Vatan Caddesi 34093 Fatih, İstanbul / TURKEY
Copyright © Bezmialem Vakıf Üniversitesi

Creative Commons Lisansı
Bezmialem Institutional Repository, Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.

OpenAccess@BVU

Support by  UNIREPOS